Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (4): 347-351.DOI: 10.3969/j.issn.1673-8640.2023.04.009
Previous Articles Next Articles
SONG Shiwei1, LI Jingwu1(), LIN Tao1, LIU Zeyu1, WANG Zhiqiang1, SUN Weidong2
Received:
2021-06-16
Revised:
2023-02-23
Online:
2023-04-28
Published:
2023-06-21
CLC Number:
SONG Shiwei, LI Jingwu, LIN Tao, LIU Zeyu, WANG Zhiqiang, SUN Weidong. Relationship between GPNMB and non-small cell lung cancer immune infiltration and prognosis[J]. Laboratory Medicine, 2023, 38(4): 347-351.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.04.009
组别 | 例数 | 性别 | 年龄/岁 | 组织分型 | TNM分期 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男/例 | 女/例 | 肺腺癌/例 | 肺鳞癌/例 | 其他分型/例 | Ⅰ期/例 | Ⅱ期/例 | Ⅲ期/例 | Ⅳ期/例 | |||
低表达组 | 21 | 10 | 11 | 55.83±14.11 | 11 | 6 | 4 | 14 | 5 | 1 | 1 |
中表达组 | 37 | 19 | 18 | 50.42±16.48 | 21 | 9 | 7 | 6 | 15 | 13 | 3 |
高表达组 | 66 | 33 | 33 | 51.57±18.49 | 36 | 17 | 13 | 3 | 17 | 36 | 10 |
统计值 | 0.075 | 0.692 | 0.151 | 47.484 | |||||||
P值 | 0.963① | 0.503 | 0.997① | <0.001① |
组别 | 例数 | 性别 | 年龄/岁 | 组织分型 | TNM分期 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男/例 | 女/例 | 肺腺癌/例 | 肺鳞癌/例 | 其他分型/例 | Ⅰ期/例 | Ⅱ期/例 | Ⅲ期/例 | Ⅳ期/例 | |||
低表达组 | 21 | 10 | 11 | 55.83±14.11 | 11 | 6 | 4 | 14 | 5 | 1 | 1 |
中表达组 | 37 | 19 | 18 | 50.42±16.48 | 21 | 9 | 7 | 6 | 15 | 13 | 3 |
高表达组 | 66 | 33 | 33 | 51.57±18.49 | 36 | 17 | 13 | 3 | 17 | 36 | 10 |
统计值 | 0.075 | 0.692 | 0.151 | 47.484 | |||||||
P值 | 0.963① | 0.503 | 0.997① | <0.001① |
1. |
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics,2020[J]. CA Cancer J Clin, 2020, 70(1):7-30.
DOI URL |
2. | YAO K, WEI L, ZHANG J, et al. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment[J]. Aging(Albany NY), 2020, 12(16):16238-16254. |
3. |
GATAA I, MEZQUITA L, ROSSONI C, et al. Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy[J]. Eur J Cancer, 2021, 145:221-229.
DOI PMID |
4. |
QUAN Y H, LIM J Y, CHOI B H, et al. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells[J]. Cancer Chemother Pharmacol, 2019, 83(3):399-410.
DOI |
5. |
KOVALEVA O V, RASHIDOVA M A, SAMOILOVA D V, et al. CHID1 is a novel prognostic marker of non-small cell lung cancer[J]. Int J Mol Sci, 2021, 22(1):450.
DOI URL |
6. |
LIU F, WANG X, YANG Y, et al. The suppressive effects of miR-508-5p on the odontogenic differentiation of human dental pulp stem cells by targeting glycoprotein non-metastatic melanomal protein B[J]. Stem Cell Res Ther, 2019, 10(1):35.
DOI PMID |
7. |
REN F, ZHAO Q, LIU B, et al. Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer[J]. J Cell Physiol, 2020, 235(3):2738-2752.
DOI PMID |
8. |
CHUNG J S, RAMANI V, KOBAYASHI M, et al. DC-HIL/Gpnmb is a negative regulator of tumor response to immune checkpoint inhibitors[J]. Clin Cancer Res, 2020, 26(6):1449-1459.
DOI URL |
9. |
MARIC G, ANNIS M G, MACDONALD P A, et al. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity[J]. Oncogene, 2019, 38(26):5294-5307.
DOI PMID |
10. |
FENG X, ZHANG L, KE S, et al. High expression of GPNMB indicates an unfavorable prognosis in glioma:combination of data from the GEO and CGGA databases and validation in tissue microarray[J]. Oncol Lett, 2020, 20(3):2356-2368.
DOI URL |
11. |
LI Y N, ZHANG L, LI X L, et al. Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer[J]. APMIS, 2014, 122(2):140-146.
DOI URL |
12. |
YARDLEY D A, WEAVER R, MELISKO M E, et al. EMERGE:a randomized phase Ⅱ study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB-expressing breast cancer[J]. J Clin Oncol, 2015, 33(14):1609-1619.
DOI URL |
13. | DOMENIGHETTI C, SUGIER P E, SREELATHA A A K, et al. Mendelian randomisation study of smoking,alcohol,and coffee drinking in relation to parkinson's disease[J]. J Parkinsons Dis, 2022, 12(1):267-282. |
14. |
XU S, FAN Y, LI D, et al. Glycoprotein nonmetastatic melanoma protein B accelerates tumorigenesis of cervical cancer in vitro by regulating the Wnt/β-catenin pathway[J]. Braz J Med Biol Res, 2018, 52(1):e7567.
DOI URL |
15. |
MA R Q, TANG Z J, YE X, et al. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer[J]. Arch Gynecol Obstet, 2018, 297(5):1235-1244.
DOI |
16. |
WANG S S, GU Q, LIU N, et al. Aerobic exercise attenuates ectopic renal sinus adipose tissue accumulation-related renal hypoxia injury in obese mice[J]. Life Sci, 2021, 279:119106.
DOI URL |
17. |
LEE-SAYER S S M, MAESHIMA N, DOUGAN M N, et al. Hyaluronan-binding by CD44 reduces the memory potential of activated murine CD8 T cells[J]. Eur J Immunol, 2018, 48(5):803-814.
DOI URL |
18. |
LI W, MA H, ZHANG J, et al. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis[J]. Sci Rep, 2017, 7(1):13856.
DOI PMID |
19. |
LEI X, LEI Y, LI J K, et al. Immune cells within the tumor microenvironment:biological functions and roles in cancer immunotherapy[J]. Cancer Lett, 2020, 470:126-133.
DOI URL |
20. |
BOULLE G, VELUT Y, MANSUET-LUPO A, et al. Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma[J]. Eur J Cancer, 2020, 135:221-229.
DOI PMID |
21. |
LI H, XIAO Y, WU C C, et al. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma[J]. Histol Histopathol, 2019, 34(7):803-810.
DOI PMID |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||